Xu Peng, Kai Chifune, Kawasaki Satoshi, Kobayashi Yuki, Yamamoto Kouji, Tsujikawa Motokazu, Hayashi Ryuhei, Nishida Kohji
Department of Ophthalmology, Osaka University Graduate School of Medicine, Osaka, Japan.
Department of Ocular Immunology and Regenerative Medicine, Osaka University Graduate School of Medicine, Osaka, Japan.
Transl Vis Sci Technol. 2018 Dec 21;7(6):30. doi: 10.1167/tvst.7.6.30. eCollection 2018 Nov.
Gelatinous drop-like corneal dystrophy (GDLD) is a rare autosomal recessive corneal dystrophy that causes severe vision loss. Because of its poor prognosis, there is a demand for novel treatments for GDLD. Here, we establish a new in vitro disease model of GDLD based on immortalized human corneal epithelial (HCE-T) cells.
By using transcription activator-like effector nuclease plasmids, tumor-associated calcium signal transducer 2 () and its paralogous gene, epithelial cell adhesion molecule (), were knocked out in HCE-T cells. Fluorescence-activated cell sorting was performed to obtain cells in which both and were knocked out (DKO cells). In DKO cells, the expression levels and subcellular localizations of claudin (CLDN) 1, 4, and 7, and ZO-1 were investigated, along with epithelial barrier function. By using DKO cells, the feasibility of gene therapy for GDLD was also investigated.
DKO cells exhibited decreased expression and aberrant subcellular localization of CLDN1 and CLDN7 proteins, as well as decreased epithelial barrier function. Transduction of the gene into DKO cells nearly normalized expression levels and subcellular localization of CLDN1 and CLDN7 proteins, while significantly increasing epithelial barrier function.
We established an in vitro disease model of GDLD by knocking out and its paralogous gene, in HCE-T cells. This cell line accurately reflected pathological aspects of GDLD.
We expect that the cell line will be useful to elucidate the pathogenesis of GDLD and develop novel treatments for GDLD.
凝胶状滴状角膜营养不良(GDLD)是一种罕见的常染色体隐性角膜营养不良,可导致严重视力丧失。由于其预后较差,对GDLD的新治疗方法有需求。在此,我们基于永生化人角膜上皮(HCE-T)细胞建立了一种新的GDLD体外疾病模型。
通过使用转录激活样效应核酸酶质粒,在HCE-T细胞中敲除肿瘤相关钙信号转导子2()及其同源基因上皮细胞粘附分子()。进行荧光激活细胞分选以获得和均被敲除的细胞(双敲除细胞,DKO细胞)。在DKO细胞中,研究了紧密连接蛋白(CLDN)1、4和7以及闭锁小带蛋白1(ZO-1)的表达水平和亚细胞定位,以及上皮屏障功能。还利用DKO细胞研究了GDLD基因治疗的可行性。
DKO细胞表现出CLDN1和CLDN7蛋白表达降低以及亚细胞定位异常,同时上皮屏障功能降低。将基因转导至DKO细胞中使CLDN1和CLDN7蛋白的表达水平和亚细胞定位几乎恢复正常,同时显著增强上皮屏障功能。
我们通过在HCE-T细胞中敲除及其同源基因建立了GDLD体外疾病模型。该细胞系准确反映了GDLD的病理特征。
我们期望该细胞系将有助于阐明GDLD的发病机制并开发GDLD的新治疗方法。